Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

6.25
Delayed Data
As of Apr 29
 +0.21 / +3.48%
Today’s Change
3.50
Today|||52-Week Range
11.86
-17.87%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close6.04
Today’s open5.96
Day’s range5.96 - 6.25
Volume7,610
Average volume (3 months)34,253
Market cap$69.4M
Dividend yield--
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)-9.09%
Earnings growth (this year)-91.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc+0.00+0.15%
CAPRCapricor Therapeutic...+0.14+3.68%
CEMIChembio Diagnostics ...-0.02-0.28%
CATBCatabasis Pharmaceut...-0.20-4.34%
Data as of 04/29/2016

Financials

Next reporting dateMay 12, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$0.00
Annual profit (last year)-$10.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs